Cargando…

Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines

Adoptive T cell transfer therapy (ACT) using tumor infiltrating lymphocytes or lymphocytes redirected with antigen receptors (CAR or TCR) has revolutionized the field of cancer immunotherapy. Although CAR T cell therapy mediates robust responses in patients with hematological malignancies, this appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwyer, Connor J., Knochelmann, Hannah M., Smith, Aubrey S., Wyatt, Megan M., Rangel Rivera, Guillermo O., Arhontoulis, Dimitrios C., Bartee, Eric, Li, Zihai, Rubinstein, Mark P., Paulos, Chrystal M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391336/ https://www.ncbi.nlm.nih.gov/pubmed/30842774 http://dx.doi.org/10.3389/fimmu.2019.00263

Ejemplares similares

Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8(+) T cells
por: Dwyer, Connor J., et al.
Publicado: (2020)

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
por: Rangel Rivera, Guillermo O., et al.
Publicado: (2021)

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
por: Knochelmann, Hannah M., et al.
Publicado: (2018)

B cells imprint adoptively transferred CD8(+) T cells with enhanced tumor immunity
por: Smith, Aubrey S, et al.
Publicado: (2022)

Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies
por: Knochelmann, Hannah M, et al.
Publicado: (2021)

Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2020)

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
por: Bowers, Jacob S., et al.
Publicado: (2019)

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)

Cancer immunotherapy: are we there yet?
por: Li, Zihai, et al.
Publicado: (2013)

Harnessing the Microbiome to Enhance Cancer Immunotherapy
por: Nelson, Michelle H., et al.
Publicado: (2015)

Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
por: Li, Zihai, et al.
Publicado: (2018)

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
por: Bartee, Eric, et al.
Publicado: (2017)

Identification of human CD4(+) T cell populations with distinct antitumor activity
por: Nelson, Michelle H., et al.
Publicado: (2020)

Th17 Cells in Cancer: The Ultimate Identity Crisis
por: Bailey, Stefanie R., et al.
Publicado: (2014)

Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities
por: Curran, Thomas, et al.
Publicado: (2021)

Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
por: Paulos, Chrystal M, et al.
Publicado: (2006)

Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
por: Chandrasekaran, Sanjay, et al.
Publicado: (2021)

PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells
por: Bowers, Jacob S., et al.
Publicado: (2017)

Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy
por: Wolfarth, Alexandra A., et al.
Publicado: (2022)

Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition
por: Knochelmann, Hannah M., et al.
Publicado: (2022)

Human CD26(high) T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
por: Bailey, Stefanie R., et al.
Publicado: (2017)

Cytokine determinants of viral tropism
por: McFadden, Grant, et al.
Publicado: (2009)

Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy
por: Bartee, Mee Y., et al.
Publicado: (2019)

Programmed death 1 (PD‐1) and ligand (PD‐L1) inhibitors in head and neck squamous cell carcinoma: A meta‐analysis
por: Levy, Dylan A., et al.
Publicado: (2022)

Role of Common-Gamma Chain Cytokines in NK Cell Development and Function: Perspectives for Immunotherapy
por: Meazza, Raffaella, et al.
Publicado: (2011)

Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries
por: Arhontoulis, Dimitrios C., et al.
Publicado: (2022)

Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries
por: Arhontoulis, Dimitrios C, et al.
Publicado: (2022)

Tumor necrosis factor and interferon: cytokines in harmony
por: Bartee, Eric, et al.
Publicado: (2008)

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE
por: Kamen, Diane L, et al.
Publicado: (2022)

Dickkopf1 fuels inflammatory cytokine responses
por: Jaschke, Nikolai P., et al.
Publicado: (2022)

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
por: Mehrotra, Shikhar, et al.
Publicado: (2017)

Interferon gamma in cancer immunotherapy
por: Ni, Ling, et al.
Publicado: (2018)

Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
por: Wang, Wuyin, et al.
Publicado: (2022)

Cytokines in Cancer Immunotherapy
por: Lee, Sylvia, et al.
Publicado: (2011)

Adhesion analysis via a tumor vasculature-like microfluidic device identifies CD8(+) T cells with enhanced tumor homing to improve cell therapy
por: Camargo, Camila P., et al.
Publicado: (2023)

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2018)

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
por: Knochelmann, Hannah M., et al.
Publicado: (2021)

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019
por: Ascierto, Paolo A, et al.
Publicado: (2020)

The interweaved signatures of common-gamma-chain cytokines across immunologic lineages
por: Baysoy, Alev, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_att776vk1j06rg8surbeit79ru